Who makes Cohort B: paridiprubart?

Cohort B: paridiprubart is developed by PPD Development, LP.

What development phase is Cohort B: paridiprubart in?

Cohort B: paridiprubart is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Cohort B: paridiprubart

PPD Development, LP · Phase 2 active Small molecule

At a glance

Generic name	Cohort B: paridiprubart
Sponsor	PPD Development, LP
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) (PHASE2)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cohort B: paridiprubart CI brief — competitive landscape report
Cohort B: paridiprubart updates RSS · CI watch RSS
PPD Development, LP portfolio CI